Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
about
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysisThe AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurineReview article: maintenance treatment of Crohn's disease.Colon capsule endoscopy: Advantages, limitations and expectations. Which novelties?Bovine colostrum increases pore-forming claudin-2 protein expression but paradoxically not ion permeability possibly by a change of the intestinal cytokine milieuEvaluation of new therapies for inflammatory bowel disease.Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?Control of systemic and local inflammation with transforming growth factor beta containing formulas.Synergy between immunosuppressive therapy and enteral nutrition in the management of childhood Crohn's disease.Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activationQuestions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.Cellular and molecular mechanism of interleukin-1β modulation of Caco-2 intestinal epithelial tight junction barrier.How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?Histologic scoring indices for evaluation of disease activity in Crohn's disease.Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.Advances in inflammatory bowel disease: are patients taking their medicines? Interview by Paul C. Adams.Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's disease.Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber.Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease“New drugs: Kids come first”: Children should be included in trials of new biological treatments
P2860
Q24608254-FC5C8BA0-FC6F-46C5-BE98-8F099B59EE09Q28594740-6AB1BB99-A991-4DB6-AB1B-598409EA4258Q33966376-230BF261-B687-49FA-B35B-DEEF5242086EQ34637725-D9FBB23E-C2B8-4EBF-BC28-5A7005E4393AQ34745430-06F252FE-7283-4A1A-B3E2-BE33C89B1DF5Q35216827-67486089-72D5-4271-B7B3-29B89DC2FF01Q36041620-C11A1A84-965F-4CE8-883B-E8B16C8D041CQ36175761-FABC0236-5FCD-4BEB-A4CC-E2FBA4D33584Q36175772-84D077FC-9B29-4FF2-949F-11D751AC3D26Q36914746-2E8351F1-457E-4432-9A6C-0EAA215AD6CDQ37442760-DCD9B94B-6D57-4A9C-ADE5-D9B37849C0EDQ37580772-AE67B226-B0AB-49AC-9D02-D1A5AE362FC0Q38026402-70399744-216A-4ED3-BD28-422DD5BD641AQ38668188-4AC9CFFF-DAB5-41ED-902C-8F3F62B4D595Q38797791-FD4AACFA-C2F9-49F5-A2A6-24430352C747Q41005661-BF9B495A-526B-4A8C-BD3C-DFDF7CFA6C40Q43113541-6414B7C6-AAB2-4548-A90C-8AABCC85371DQ45242446-61C34790-F4DA-4BCD-9B64-EF2A55C05C5EQ50922715-5A3EF4E9-ABC2-4F21-9A6E-4183E5DFD66AQ51618737-84E3C337-CA28-472B-BE31-BB0A66AC588AQ57675111-73353922-A521-4FBB-B7D4-1B7228B6A903Q57804309-B1520FB8-F2C6-4120-B6FF-C0CCB2120660
P2860
Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Review article: is clinical re ...... treatment of Crohn's disease?
@ast
Review article: is clinical re ...... treatment of Crohn's disease?
@en
Review article: is clinical re ...... treatment of Crohn's disease?
@nl
type
label
Review article: is clinical re ...... treatment of Crohn's disease?
@ast
Review article: is clinical re ...... treatment of Crohn's disease?
@en
Review article: is clinical re ...... treatment of Crohn's disease?
@nl
prefLabel
Review article: is clinical re ...... treatment of Crohn's disease?
@ast
Review article: is clinical re ...... treatment of Crohn's disease?
@en
Review article: is clinical re ...... treatment of Crohn's disease?
@nl
P2093
P2860
P1476
Review article: is clinical re ...... treatment of Crohn's disease?
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2002.01242.X
P407
P577
2002-05-01T00:00:00Z